Welcome to ULS!
Welcome to ULS!
> Products > Research Areas > Neurological Disease
Products
Neurological Disease

Chemical structure

Cat.No.

Product Name

CAS no.

Target

  • YN370271 Stiripentol 49763-96-4

    Stiripentol is a third-generation anti-epileptic drug that enhances GABAergic neurotransmission. It is an inhibitor of cytochrome P450.

  • YN360737 Vecuronium bromide 50700-72-6

    Vecuronium is a non-depolarizing neuromuscular blocking agent, used for skeletal muscle relaxation during surgery.

  • YN482750 Hastatoside 50816-24-5

    Hastatoside is an iridoid glycoside that is isolated fromVerbena officinalis and has a role in promoting sleep.

  • YN482306 Coelenterazine h 50909-86-9

    Coelenterazine h is a derivative of Coelenterazine. Coelenterazine h is more sensitive to Ca2+than is the native complex, thus providing a valuable tool for measuring small changes in Ca2+concentrations.

  • YN1730105 Tiapride hydrochloride 51012-33-0

    Tiapride is a drug that selectively blocks D2 and D3 dopamine receptors in the brain and is used to treat a variety of neurological and psychiatric disorders.

  • YN321734 Isocorynoxeine 51014-29-0

    Isocorynoxeine, an isorhynchophylline-related alkaloid, exhibits a dose-dependent inhibition of 5-HT2A receptor-mediated current response with an IC50 of 72.4 μM.

  • YN321747 Licarin A 51020-86-1

    Licarin A ((+)-Licarin A), a neolignan isolated from various plants, significantly and dose-dependently reduces TNF-α production (IC50=12.6±0.3μM) in dinitrophenyl-human serum albumin (DNP-HSA)-stimulated RBL-2H3 ce...

  • YN483728 Somatostatin 51110-01-1

    Somatostatin is a tetradecapeptide which can suppress the growth hormone (GH) secretion and control the pituitary hormone secretion in human CNS.

  • YN360079 8-Bromo-cGMP sodium 51116-01-9

    8-Bromo-cGMP sodium, a membrane-permeable analogue of cGMP, is aPKG (protein kinase G)activator and significantly inhibitsCa2+macroscopic currents and impairs insulin release stimulated with high K+. 8-Bromo-cGMP sodium...

  • YN321944 Substance P (7-11) 51165-05-0

    Substance P (7-11) is a C-terminal fragment of Substance P which can cause an increase in the intracellular calcium concentration.

  • YN484423 Glufosinate 51276-47-2

    Glufosinate, a phosphinic acid analogue of glutamic acid, is a herbicide which is converted by plant cells into PT (L-phosphinothricin). Glufosinate exerts neurotoxic activity.

  • YN321417 Tizanidine 51322-75-9

    Tizanidine is an imidazoline derivative and a centrally acting α2 adrenergic agonist used as a muscle relaxant for therapy of acute muscle spasms and chronic spasticity.

  • YN321040 cis-(Z)-Flupentixol dihydroc... 51529-01-2

    Flupentixol, an antipsychotic neuroleptic drug, is a powerful antagonist of both D1 and D2 dopamine receptors and also an alpha-adrenergic receptor antagonist.

  • YN370253 Tarenflurbil 51543-40-9

    Tarenflurbil ((R)-Flurbiprofen) is the R-enantiomer of the racemate NSAID Flurbiprofen, Tarenflurbil ((R)-Flurbiprofen) inhibits the binding of [3H]9-cis-RA toRXRαLBD with IC50 of 75μM.

  • YN322027 Cimetropium Bromide 51598-60-8

    Cimetropium Bromide (DA-3177) is amAChRantagonist for long-term treatment of irritable bowel syndrome.

  • YN321739 2'-O-Methylisoliquiritigenin 51828-10-5

    2'-O-Methylisoliquiritigenin, isolated from theArachisspecies, up-regulates5-HT, NE, DA and GABApathways, but does not put a very significant effect on ne NE pathway.

  • YN360832 Pipecuronium bromide 52212-02-9

    Pipecuronium bromide is a potent long-acting nondepolarizing steroidal neuromuscular blocking agent (NMBA), and a bisquaternary ammonium compound. Pipecuronium bromide is a powerful competitivenAChRantagonist with aKdof 3.06μM...

  • YN360936 Ginsenoside Rf 52286-58-5

    Ginsenoside Rf is a trace component of ginseng root. Ginsenoside Rf inhibitsN-type Ca2+channel.

  • YN350220 Ginsenoside Re 52286-59-6

    Ginsenoside Re is a major ginsenoside in ginseng and belongs to 20(S)-protopanaxatriol group. It has diverse in vitro and in vivo effects, including vasorelaxant, antioxidant, antihyperlipidemic, and angiogenic actions.

  • YN380231 Ginsenoside Rg2 52286-74-5

    (20S)Ginsenoside Rg2, a constituent existing in red ginseng, has been reported to exert strong inhibitory action on various cancer cells.

    Contact

    TELL : +86-020-82000279

    Email: sales@ubiochem.com

    Add:Room 519, Block F, Guangzhou International Business Incubator, No.3 Lanyue Road, Science Town, Huangpu District, Guangzhou, China.

ULS products are chemical reagents for Research Use Only!Copyright © 2020-2021 ULS. All Rights Reserved.备案号:粤ICP备2021013238号-2
1.838683s